Orion Infusions (DHA:ORIONINFU) Short-Term Capital Lease Obligation : BDT6.2 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Short-Term Capital Lease Obligation?

Orion Infusions's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was BDT6.2 Mil.

Orion Infusions's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (BDT10.1 Mil) to Dec. 2023 (BDT6.8 Mil) and declined from Dec. 2023 (BDT6.8 Mil) to Mar. 2024 (BDT6.2 Mil).

Orion Infusions's annual Short-Term Capital Lease Obligation declined from Jun. 2021 (BDT11.8 Mil) to Jun. 2022 (BDT11.6 Mil) and declined from Jun. 2022 (BDT11.6 Mil) to Jun. 2023 (BDT10.3 Mil).

Orion Infusions Short-Term Capital Lease Obligation Historical Data

The historical data trend for Orion Infusions's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Short-Term Capital Lease Obligation Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

11.49

11.75

11.63

10.32

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															10.22	10.32	10.15	6.81	6.24

Orion Infusions Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Orion Infusions Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines